SB 641 California Senate · 2023-2024 Regular Session

Public health: alcohol and drug programs: naloxone.

Summary
Existing law establishes the State Department of Health Care Services within the California Health and Human Services Agency. Existing law sets forth the department's powers and duties, including receiving federal funds payable directly to the state by the Substance Abuse and Mental Health Services Administration to implement programs that provide services to alleviate the problems related to alcohol and other drug use. The Naloxone Distribution Project (NDP) is administratively created by the department to reduce opioid-related overdose deaths. This bill would require the department, as part of the NDP, to make all United States Food and Drug Administration-approved formulations and dosage strengths of naloxone or any other opioid antagonist that are indicated for the emergency treatment of known or suspected opioid overdose available through the NDP, as specified. The bill would make legislative findings and declarations.
Bill status vetoed 4 of 5 stages cleared
Introduction
Feb 2023
Committee Review
Jun 2023
Senate Passage
May 2023
Assembly Passage
Sep 2023
Vetoed
Jan 2024
Introduced Feb 16, 2023 Vetoed Jan 25, 2024
Floor votes · Senate May 25, 2023 · Assembly Sep 14, 2023

How they voted

40–0
Passed
Total votes 40
May 25, 2023
D Democratic31
31 Yea
100% Yea
R Republican9
9 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
31
Key actions
11
Committee
5
Amendments
7
Jan 25, 2024
Vetoed
Veto sustained.
upper
Oct 8, 2023
Vetoed
In Senate. Consideration of Governor's veto pending.
upper
Oct 8, 2023
Vetoed
Vetoed by the Governor.
upper
Sep 14, 2023
Assembly · Passed
Assembly Vote: pass (76-0-4)
assembly
Sep 14, 2023
Upper · Passed
Assembly amendments concurred in. (Ayes 40. Noes 0. Page 2846.) Ordered to engrossing and enrolling.
upper
Sep 13, 2023
Introduced
In Senate. Concurrence in Assembly amendments pending.
upper
Sep 13, 2023
Lower · Passed
Read third time. Passed. (Ayes 76. Noes 0. Page 3462.) Ordered to the Senate.
lower
Sep 1, 2023
Lower · Passed
Read second time and amended. Ordered to second reading.
lower
Sep 1, 2023
Lower · Passed
From committee: Do pass as amended. (Ayes 11. Noes 0.) (September 1).
lower
Jun 21, 2023
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 14. Noes 0.) (June 20). Re-referred to Com. on APPR.
lower
Jun 8, 2023
Committee
Referred to Com. on HEALTH.
lower
May 25, 2023
Upper · Passed
Read third time. Passed. (Ayes 40. Noes 0. Page 1303.) Ordered to the Assembly.
upper
May 18, 2023
Upper · Passed
From committee: Do pass. (Ayes 7. Noes 0. Page 1178.) (May 18).
upper
May 1, 2023
Upper · Passed
Read second time and amended. Re-referred to Com. on APPR.
upper
Apr 27, 2023
Upper · Passed
From committee: Do pass as amended and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 941.) (April 26).
upper
Mar 29, 2023
Committee
Re-referred to Com. on HEALTH.
upper
Mar 20, 2023
Upper · Passed
From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.
upper
Mar 1, 2023
Committee
Referred to Com. on RLS.
upper
Feb 16, 2023
Introduced
Introduced. Read first time. To Com. on RLS. for assignment. To print.
upper
1 primary · 3 co-sponsors

Sponsors